InterMune, Inc.

InterMune, Inc.

Sector: Biological Products Except Diagnostic Substances Region: CA, United States

: | Nasdaq: ITMN | Frankfurt Stock Exchange: IUX

Similar to: Bebra Biogas Holding AG, BioTime, Inc., NPS Pharmaceuticals, Inc.

InterMune, Inc. is a biotechnology company that is focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. It is focused on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The company's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. InterMune was founded in 1998 and is headquartered in Brisbane, CA.

News & Analysis

You may also be interested in: